TCI
>
Innovations
>
Scientific Publications
>
Bifidobacterium lactis ameliorates AOM/DSS-induced inflammation, dysbiosis, and colonic precancerous lesions
Bifidobacterium lactis ameliorates AOM/DSS-induced inflammation, dysbiosis, and colonic precancerous lesions
Paper Title
Bifidobacterium lactis ameliorates AOM/DSS-induced inflammation, dysbiosis, and colonic precancerous lesions
| Ingredient | TCI604 Bifidobacterium lactis |
|---|---|
| Benefit | Gut Health |
| Study Type | Animal Study |
| Journal | Applied Microbiology and Biotechnology. 2025; 109:69 DOI: 10.1007/s00253-025-13445-x |
* This page summarizes a study published by TCI in a peer-reviewed journal. Please refer to the original journal for full details.